American Trust’s Pediatrix Medical MD Stock Holding History

American Trust’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,879	Closed	-$326K	–	489
2022 Q1	$326K	Buy	13,879 +4,263	+44%	+$104K	0.02%	330
2021 Q4	$262K	Buy	+9,616	New	+$257K	0.02%	269

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

American Trust's MD Position: Q2 2022 in Review

American Trust sold out of Pediatrix Medical (MD) in Q2 2022, closing a stake of 13,879 shares — an estimated $326K sold.

American Trust first reported a position in MD in Q4 2021 and held it in 2 quarters. The position peaked at $326K in Q1 2022. 198 funds tracked by Wall St. Rank hold MD as of Q2 2022.

American Trust reported no remaining Pediatrix Medical position as of Q2 2022 after selling out during the quarter.
American Trust sold 13,879 Pediatrix Medical shares in Q2 2022, an estimated $326K.
American Trust first reported a position in Pediatrix Medical in Q4 2021 and held it in 2 quarters.
American Trust's Pediatrix Medical position peaked at $326K in Q1 2022.
198 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2022.

Based on American Trust's 13F filing for Q2 2022, filed 3 Oct 2022.